Skip to main content
PRAX logo

Praxis Precision Medicines, Inc.

PRAXNASDAQHealthcareBiotechnology

$258.92Today:- (-)1Y +45.45%

As of Oct 22, 2026 close

Market cap
$7.54B
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$154.45$392.70
Volume (live)
-
Avg. volume (3M)
544.14K

Praxis Precision Medicines, Inc. (PRAX) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Praxis Precision Medicines, Inc. stock.

Analyst Consensus Rating

Investment consensus from 18 professional research analysts

Consensus Rating

Buy
Based on 18 unique analysts
(22 total ratings in last 90 days)
High Confidence∞:1 Buy/Sell

Average Price Target

$702.18
+171.20% upside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest PRAX Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Douglas Tsao
HC Wainwright
BuyMaintains
$1201.00
Tessa Romero
JP Morgan
BuyInitiates
$700.00
Joon Lee
UBS
BuyInitiates
$706.00
Kambiz Yazdi
BTIG
BuyReiterates
$810.00 → $826.00
Douglas Tsao
HC Wainwright
BuyMaintains
$1201.00
Justin Walsh
JonesTrading
BuyReiterates
$441.00 → $534.00
Ami Fadia
Needham
BuyReiterates
$582.00
Bret Jensen
TheStreet.com
BuyInitiates Coverage
-
Kevin Strang
Goldman Sachs
BuyInitiates Coverage
$470.00 → $575.00
Kevin Strang
Goldman Sachs
BuyReiterates
$470.00 → $575.00
Jay Olson
Oppenheimer
BuyReiterates
$650.00
Jay Olson
Oppenheimer
BuyReiterates
$650.00
Tiago Fauth
Raymond James
BuyMaintains
$765.00 → $945.00
Francois Brisebois
LifeSci Capital
BuyInitiates Coverage
$754.00
Yasmeen Rahimi
Piper Sandler
BuyMaintains
$1200.00
Danielle Brill
Truist
BuyMaintains
$616.00
Benjamin Burnett
Wells Fargo
HoldMaintains
$323.00 → $362.00
Brian Skorney
Baird
BuyMaintains
$400.00 → $514.00
Yatin Suneja
Guggenheim
BuyReiterates
$800.00
Ritu Baral
TD Cowen
BuyMaintains
$510.00
Ami Fadia
Needham
BuyMaintains
$575.00 → $582.00
Leonid Timashev
RBC Capital
BuyInitiates Coverage
$449.00 → $462.00

Source: Professional analyst ratings and price targets from the last 90 days. Data as of Oct 15, 2026. Data sources and methodology

Frequently Asked Questions

What is the analyst consensus rating for PRAX?

The analyst consensus rating for PRAX is Buy, based on the latest ratings from 18 analysts over the last 90 days.

What is the average price target for PRAX?

The average 12-month price target for PRAX is $702.18, representing an upside of 171.2% from the Oct 22, 2026 close of $258.92.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.